Developer docs
API playgroundTry for free, no card

Search company profiles

Cellibre

Full company profile

uuid0000zyx

Namestring
Cellibre
Legal namestring
Cellibre, Inc.
Websiteurl
cellibre.com
Company typeenum
Private
Founded yearint
2019
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Diego, United States
HQ citystring
San Diego
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
precision fermentation, synthetic biology, natural ingredients, cellular agriculture, biomanufacturing
Industry3 codes
PRIMARYAFAKAGAH
Fermentation-Derived Alternative Proteins Manufacturing (Precision Fermentation)
Agriculture & Food Production/Food Processing & Manufacturing/Plant-Based & Alternative Protein Foods Manufacturing
SECONDARYEUAAAIAL
Enzymes & Industrial Biotechnology Inputs (Enzymes, Microbial Strains, Fermentation Aids)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYIMALAMAB
Compostable & Bio-Based Packaging (PLA/PHA, Starch Blends, Cellulose Films)
NAICS code1 code
  • Medicinal and Botanical Manufacturing325411
SIC code1 code
  • Medicinal Chemicals & Botanical Products2833
Product category
Precision Fermentation Ingredients
Social media profiles3 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Ingredient Sales (Direct B2B)
TypeOne Time License
Description

Direct sale of fermentation-produced natural ingredients (Bakuchiol, Resveratrol, Naringenin) to manufacturers in beauty, food, pharmaceutical, and cosmetic industries. Revenue generated from commercial products at various stages from commercial titers to pilot/successfully piloted products.

cellibre.com
2Strategic Partnership Revenue
TypeLicensing Royalties
Description

Partnership agreements with major flavor and cosmetic ingredient companies like Symrise providing preferred access to proprietary technology platform for developing next-generation manufacturing technologies and high-value natural ingredients.

cultivated-x.com
3Platform Development Services
TypeProfessional Services
Description

Custom development and optimization services for producing specific molecules through precision fermentation. Includes strain development, process optimization, and scale-up services potentially structured as project-based or milestone payments.

cellibre.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations
Pricing details1 tier
1Custom ingredient sales with quote-based pricing
ModelOtherBilling cadenceMulti-year contract
Notes

Products are sold directly to B2B customers with pricing determined by volume, specifications, and contract terms. Sample requests available via order form.

cellibre.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Cellibre turns cells into specialized, sustainable factories for the manufacture of high-value natural ingredients at scale using precision fermentation technology. The company produces ingredients such as Bakuchiol (vegan retinol alternative for skincare), Resveratrol (multi-therapeutic polyphenol), and Naringenin (clean beauty flavonoid) by engineering microorganisms to manufacture complex organic molecules sustainably, replacing agricultural extraction with fermentation-based production.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Commercial production of Bakuchiol expected by 2025, providing sustainable alternative to retinol
+2 more records
Product overview1 text field

Cellibre operates a precision fermentation platform encompassing three named commercial/pipeline ingredients — Bakuchiol (a natural retinol replacement for skin care), Resveratrol (a multi-therapeutic ingredient targeting inflammation, cardiovascular, and neurodegenerative conditions), and Naringenin (a flavonoid for clean beauty and health applications) — plus an undisclosed Product B. The company also provides internal strain engineering, biochemistry/protein engineering, and bioprocessing-as-a-service capabilities across its platform. All products share the company's core precision fermentation technology, with some ingredients produced internally (I) and others partnered (P).

Product and service4 records
1Bakuchiol
CategoryCosmetic Active Ingredient
Description

A natural, vegan retinol replacement produced via precision fermentation that helps prevent fine lines and wrinkles while improving skin firmness and elasticity. It is a less irritating alternative to traditional retinol, targeting cosmetic and skincare brands seeking clean beauty ingredients.

2Resveratrol
CategoryPharmaceutical and Health Ingredient
Description

A precision fermentation-produced polyphenol ingredient with reported anticancer, antioxidant, anti-inflammatory, immunomodulatory, glucose and lipid regulatory, neuroprotective, and cardiovascular protective effects. Targeting pharmaceutical and health supplement manufacturers for conditions including cardiovascular diseases, cancer, liver diseases, obesity, diabetes, Alzheimer's disease, and Parkinson's disease.

3Naringenin
CategoryFlavonoid Ingredient
Description

A precision fermentation-produced flavonoid with potential therapeutic benefits including antioxidant, antitumor, antiviral, antibacterial, anti-inflammatory, antiadipogenic, and cardioprotective effects. Targeted for clean beauty applications improving skin health span and flavoring/antioxidant uses.

4Product B
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2025-10-01
Description

Symrise, a global supplier of fragrances, flavorings, cosmetic active ingredients, and functional ingredients, made a strategic equity investment in Cellibre. The partnership provides Symrise with preferred access to Cellibre's proprietary precision fermentation-based technology to develop next-generation manufacturing technologies for globally important ingredients. The collaboration aims to accelerate commercialization of high-value natural flavor ingredients and cosmetic bioactives, while helping Symrise achieve supply chain resilience and sustainability commitments.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

Cellibre joined BioMADE, a Department of Defense initiative and national manufacturing innovation institute for industrial biotechnology. The partnership focuses on advancing sustainable biomanufacturing technologies through workshops, knowledge sharing, and ecosystem collaboration.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Conagen is a precision fermentation company producing high-value ingredients including flavors, fragrances, vitamins, and cosmetics actives using its own strain engineering platform. It is the closest direct peer to Cellibre given its similar organism-agnostic approach and focus on sustainable natural ingredient production via fermentation.

TypeBroad incumbent
Description

Ginkgo Bioworks is a well-capitalized synthetic biology platform that programs cells for industrial applications across flavors, fragrances, cosmetics, and food ingredients. It competes for the same end-customer relationships and has acquired Zymergen, making it a broad incumbent with vastly greater resources than Cellibre.

TypeDirect peer
Description

Amyris used precision fermentation to produce specialty ingredients including squalene, resveratrol, and other botanical molecules for cosmetics and flavors, and filed for bankruptcy in 2023. It is the canonical cautionary comparable for Cellibre, sharing the same technology paradigm and end-markets but illustrating the execution risks of scaling fermentation-derived ingredients.

TypeEmerging player
Description

Lygos rebranded as Eve Bio and focuses on producing specialty chemicals and bio-based ingredients via precision fermentation, including organic acids and cannabinoid precursors. It overlaps with Cellibre's fermentation-derived natural ingredient strategy and shares a similar scale and emerging commercial stage.

TypeEmerging player
Description

Checkerspot uses precision fermentation to produce novel oils and polyols for cosmetics, personal care, and performance materials. It directly competes with Cellibre in fermentation-derived cosmetic actives and shares a similar end-market focus on clean beauty and sustainable ingredients.

TypeEmerging player
Description

Motif FoodWorks develops fermentation-derived ingredients for taste, texture, and nutrition applications in plant-based and alternative food products. It is comparable to Cellibre's Ajinomoto NGT3 win pathway, addressing food and nutrition ingredient markets through precision fermentation.

TypeEmerging player
Description

Perfect Day produces animal-free dairy proteins (whey and casein) using precision fermentation, supplying major CPG and food service companies. It is a leading commercial-stage precision fermentation peer and validates the broader market acceptance of fermentation-derived ingredients.

TypeEmerging player
Description

C16 Biosciences uses precision fermentation to produce sustainable palm oil alternatives for the cosmetics and food industries. It overlaps with Cellibre's value proposition of replacing plant extraction with fermentation and serves similar clean beauty and sustainability-focused end customers.

TypeEmerging player
Description

Cradle offers AI-driven protein design and engineering software for biotech applications including industrial enzymes and therapeutics. It is comparable to Cellibre's Anax platform as a competitor or potential partner in the AI-driven enzyme and protein optimization layer of precision fermentation.

10Culture Biosciences
TypeOthers
Description

Culture Biosciences provides fermentation-as-a-service and high-throughput fermentation screening infrastructure to biotech companies. It is an enabling service provider rather than direct competitor but is comparable to Cellibre's high-throughput fermentation screening and pilot-scale capabilities.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors10 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cellibre

Precision Fermentation Ingredientscellibre.com

Cellibre firmographics

Firmographics
Name
Cellibre
Legal name
Cellibre, Inc.
Website
https://cellibre.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Cellibre industry classification

Industry
Product category
Precision Fermentation Ingredients
NAICS
Medicinal and Botanical Manufacturing (325411)
SIC
Medicinal Chemicals & Botanical Products (2833)
akta.pro industry
PRIMARYAFAKAGAH
Fermentation-Derived Alternative Proteins Manufacturing (Precision Fermentation)
Agriculture & Food Production/Food Processing & Manufacturing/Plant-Based & Alternative Protein Foods Manufacturing
SECONDARYEUAAAIAL
Enzymes & Industrial Biotechnology Inputs (Enzymes, Microbial Strains, Fermentation Aids)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYIMALAMAB
Compostable & Bio-Based Packaging (PLA/PHA, Starch Blends, Cellulose Films)

Keywords

  • Precision fermentation
  • Synthetic biology
  • Natural ingredients
  • Cellular agriculture
  • Biomanufacturing

Where Cellibre is headquartered

Location

Headquarters

HQ city
San Diego
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Cellibre business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. Ingredient Sales (Direct B2B): Direct sale of fermentation-produced natural ingredients (Bakuchiol, Resveratrol, Naringenin) to manufacturers in beauty, food, pharmaceutical, and cosmetic industries. Revenue generated from commercial products at various stages from commercial titers to pilot/successfully piloted products.
  2. Strategic Partnership Revenue: Partnership agreements with major flavor and cosmetic ingredient companies like Symrise providing preferred access to proprietary technology platform for developing next-generation manufacturing technologies and high-value natural ingredients.
  3. Platform Development Services: Custom development and optimization services for producing specific molecules through precision fermentation. Includes strain development, process optimization, and scale-up services potentially structured as project-based or milestone payments.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom ingredient sales with quote-based pricing

Go-to-market motion3 records

Distribution channels2 records

Marketing channels6 records

Cellibre product offering

Product offering

Core offering

Cellibre turns cells into specialized, sustainable factories for the manufacture of high-value natural ingredients at scale using precision fermentation technology. The company produces ingredients such as Bakuchiol (vegan retinol alternative for skincare), Resveratrol (multi-therapeutic polyphenol), and Naringenin (clean beauty flavonoid) by engineering microorganisms to manufacture complex organic molecules sustainably, replacing agricultural extraction with fermentation-based production.

Product overview

Cellibre operates a precision fermentation platform encompassing three named commercial/pipeline ingredients — Bakuchiol (a natural retinol replacement for skin care), Resveratrol (a multi-therapeutic ingredient targeting inflammation, cardiovascular, and neurodegenerative conditions), and Naringenin (a flavonoid for clean beauty and health applications) — plus an undisclosed Product B. The company also provides internal strain engineering, biochemistry/protein engineering, and bioprocessing-as-a-service capabilities across its platform. All products share the company's core precision fermentation technology, with some ingredients produced internally (I) and others partnered (P).

Differentiator

Problem solved

Functional benefit

Products and services

  • Bakuchiol A natural, vegan retinol replacement produced via precision fermentation that helps prevent fine lines and wrinkles while improving skin firmness and elasticity. It is a less irritating alternative to traditional retinol, targeting cosmetic and skincare brands seeking clean beauty ingredients.
  • Resveratrol A precision fermentation-produced polyphenol ingredient with reported anticancer, antioxidant, anti-inflammatory, immunomodulatory, glucose and lipid regulatory, neuroprotective, and cardiovascular protective effects. Targeting pharmaceutical and health supplement manufacturers for conditions including cardiovascular diseases, cancer, liver diseases, obesity, diabetes, Alzheimer's disease, and Parkinson's disease.
  • Naringenin A precision fermentation-produced flavonoid with potential therapeutic benefits including antioxidant, antitumor, antiviral, antibacterial, anti-inflammatory, antiadipogenic, and cardioprotective effects. Targeted for clean beauty applications improving skin health span and flavoring/antioxidant uses.
  • Product B

Quantifiable outcome

  • Commercial production of Bakuchiol expected by 2025, providing sustainable alternative to retinol
  • +2 more outcomes

Companies that use Cellibre

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Cellibre technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature5 records

Cellibre partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered flagship and core.

  • SymriseflagshipStrategic or Co-development Partner · 1 October 2025Symrise, a global supplier of fragrances, flavorings, cosmetic active ingredients, and functional ingredients, made a strategic equity investment in Cellibre. The partnership provides Symrise with preferred access to Cellibre's proprietary precision fermentation-based technology to develop next-generation manufacturing technologies for globally important ingredients. The collaboration aims to accelerate commercialization of high-value natural flavor ingredients and cosmetic bioactives, while helping Symrise achieve supply chain resilience and sustainability commitments.
  • BioMADE (Bioindustrial Manufacturing and Design Ecosystem)coreStrategic or Co-development Partner · 1 January 2024Cellibre joined BioMADE, a Department of Defense initiative and national manufacturing innovation institute for industrial biotechnology. The partnership focuses on advancing sustainable biomanufacturing technologies through workshops, knowledge sharing, and ecosystem collaboration.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Cellibre competitors and assessment

Company assessment

Direct peers

  • Conagen: Conagen is a precision fermentation company producing high-value ingredients including flavors, fragrances, vitamins, and cosmetics actives using its own strain engineering platform. It is the closest direct peer to Cellibre given its similar organism-agnostic approach and focus on sustainable natural ingredient production via fermentation.
  • Amyris: Amyris used precision fermentation to produce specialty ingredients including squalene, resveratrol, and other botanical molecules for cosmetics and flavors, and filed for bankruptcy in 2023. It is the canonical cautionary comparable for Cellibre, sharing the same technology paradigm and end-markets but illustrating the execution risks of scaling fermentation-derived ingredients.

Broad incumbents

  • Ginkgo Bioworks: Ginkgo Bioworks is a well-capitalized synthetic biology platform that programs cells for industrial applications across flavors, fragrances, cosmetics, and food ingredients. It competes for the same end-customer relationships and has acquired Zymergen, making it a broad incumbent with vastly greater resources than Cellibre.

Emerging players

  • Eve Bio (formerly Lygos): Lygos rebranded as Eve Bio and focuses on producing specialty chemicals and bio-based ingredients via precision fermentation, including organic acids and cannabinoid precursors. It overlaps with Cellibre's fermentation-derived natural ingredient strategy and shares a similar scale and emerging commercial stage.
  • Checkerspot: Checkerspot uses precision fermentation to produce novel oils and polyols for cosmetics, personal care, and performance materials. It directly competes with Cellibre in fermentation-derived cosmetic actives and shares a similar end-market focus on clean beauty and sustainable ingredients.
  • Motif FoodWorks: Motif FoodWorks develops fermentation-derived ingredients for taste, texture, and nutrition applications in plant-based and alternative food products. It is comparable to Cellibre's Ajinomoto NGT3 win pathway, addressing food and nutrition ingredient markets through precision fermentation.
  • Perfect Day: Perfect Day produces animal-free dairy proteins (whey and casein) using precision fermentation, supplying major CPG and food service companies. It is a leading commercial-stage precision fermentation peer and validates the broader market acceptance of fermentation-derived ingredients.
  • C16 Biosciences: C16 Biosciences uses precision fermentation to produce sustainable palm oil alternatives for the cosmetics and food industries. It overlaps with Cellibre's value proposition of replacing plant extraction with fermentation and serves similar clean beauty and sustainability-focused end customers.
  • Cradle: Cradle offers AI-driven protein design and engineering software for biotech applications including industrial enzymes and therapeutics. It is comparable to Cellibre's Anax platform as a competitor or potential partner in the AI-driven enzyme and protein optimization layer of precision fermentation.

Others

  • Culture Biosciences: Culture Biosciences provides fermentation-as-a-service and high-throughput fermentation screening infrastructure to biotech companies. It is an enabling service provider rather than direct competitor but is comparable to Cellibre's high-throughput fermentation screening and pilot-scale capabilities.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Cellibre social profiles

Digital presence

Cellibre financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cellibre leadership team

Management profile

Number of profiles

Profiles4 records

Cellibre funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cellibre M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cellibre

What does Cellibre do?

Cellibre turns cells into specialized, sustainable factories for the manufacture of high-value natural ingredients at scale using precision fermentation technology. The company produces ingredients such as Bakuchiol (vegan retinol alternative for skincare), Resveratrol (multi-therapeutic polyphenol), and Naringenin (clean beauty flavonoid) by engineering microorganisms to manufacture complex organic molecules sustainably, replacing agricultural extraction with fermentation-based production.

Is Cellibre a public or private company?

Cellibre is a private company. It is classified as venture growth investor backed and is currently operating.

When was Cellibre founded?

Cellibre was founded in 2019. It employs 11 to 50 people.

Where is Cellibre based?

Cellibre is headquartered in San Diego, United States, in the North America region.

How does Cellibre make money?

Three revenue lines are on record. Ingredient Sales (Direct B2B) is the primary driver. The others are strategic Partnership Revenue and platform Development Services.

Who are Cellibre's main competitors?

Direct peers on record are Conagen and Amyris. Ginkgo Bioworks is listed as a broad incumbent. Emerging players are Eve Bio (formerly Lygos), Checkerspot, Motif FoodWorks, Perfect Day, C16 Biosciences and Cradle. Culture Biosciences is listed as an others.

Does Cellibre have an API?

No public API is recorded for Cellibre.

What industry is Cellibre in?

Cellibre's product category is Precision Fermentation Ingredients. Its primary akta.pro industry code is AFAKAGAH, Fermentation-Derived Alternative Proteins Manufacturing (Precision Fermentation), with a secondary code of EUAAAIAL, Enzymes & Industrial Biotechnology Inputs (Enzymes, Microbial Strains, Fermentation Aids). Its NAICS code is 325411 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
WebWireSymrise invests in Cellibre, a U.S.-based biotechnology company, to accelerate innovation for taste balancing and cosmetic actives marketsSymrise, a German flavors and fragrances company, has made a strategic equity investment in Cellibre, a U.S.-based biotechnology company specializing in sustainable biomanufacturing through precision fermentation. The investment gives Symrise preferred access to Cellibre's proprietary fermentation platform for scalable production of high-value natural ingredients across food, beverage, cosmetics, and nutraceutical sectors. The partnership aims to strengthen Symrise's supply chain resilience, accelerate biotechnology innovation, and expand its portfolio in taste balancing and clean beauty markets.Cultivated XSymrise Invests in Cellibre’s Advanced Precision Fermentation PlatformSymrise, a global supplier of fragrances, flavorings, cosmetic active ingredients, and functional ingredients, has announced a strategic equity investment in US biotech company Cellibre. Through the partnership, Symrise will gain preferred access to Cellibre's proprietary precision fermentation-based technology to develop next-generation manufacturing technologies for globally important ingredients, enabling accelerated commercialization of high-value natural flavor ingredients and cosmetic bioactives. The collaboration aims to help Symrise integrate biotechnology across its operations, achieve long-term supply chain resilience, portfolio diversification, and competitive advantage while meeting sustainability commitments.IndianchemicalnewsSymrise invests in US-based biotech firm Cellibre to accelerate innovation in fermentation-derived ingredientsSymrise has made a strategic equity investment in U.S.-based biotechnology firm Cellibre to accelerate innovation in fermentation-derived ingredients. This partnership provides Symrise with preferred access to proprietary technology for scalable production of high-value ingredients across food, beverage, and cosmetics sectors. The move aims to strengthen Symrise's supply chain resilience and sustainability leadership by leveraging Cellibre's biomanufacturing expertise.vegconomistSymrise Invests in Cellibre’s Advanced Precision Fermentation PlatformSymrise, a global supplier of fragrances, flavorings, and cosmetic ingredients, has announced a strategic equity investment in US biotech company Cellibre. Through this partnership, Symrise gains preferred access to Cellibre's proprietary precision fermentation technology to develop next-generation manufacturing processes for natural flavor ingredients and cosmetic bioactives. The collaboration aims to make supply chains more resilient by mitigating seasonal and cultivation variability while accelerating commercialization of high-value natural products.SynBioBetaSymrise and Cellibre Partner to Deliver Precision-Fermented Products TodayGlobal ingredients company Symrise has made a strategic equity investment in biotech firm Cellibre to commercialize precision-fermented products for the food and cosmetics sectors. The partnership aims to leverage Cellibre's proprietary fermentation platform to deliver cost-effective, high-quality bioactives with greater supply chain resilience than traditional methods. Over the next 12 months, the companies plan to launch initial taste modulation and cosmetic ingredient products.San Diego Business JournalAlgenesis, Cellibre, Onego Receive Pentagon FundingThe Pentagon awarded funding to three companies, Algenesis, Cellibre, and Onego, to strengthen supply chains for key industrial ingredients as part of its Distributed Bioindustrial Manufacturing Program on September 13. Algenesis received $1.5 million, Cellibre got $1.54 million, and Onego was awarded $2 million to plan facilities aimed at domestic production of critical materials. This initiative highlights the increasing focus on national security and domestic production capabilities in response to supply chain vulnerabilities exposed during the COVID-19 pandemic.SecSEC FORM DCellibre, Inc. filed a Form D with the SEC for an exempt securities offering under Rule 506(b) with a total offering amount of approximately $23.2 million. The filing indicates that $6.7 million has been sold to 31 investors since the first sale on September 30, 2024. The company is based in San Diego, California, and operates within the biotechnology sector.Business Wire BlogCellibre Receives DoD Funding to Prepare for Commercialization of Their Manufacturing Technologies for Critical Polymers, Energetics and Platform Chemicals to Bolster Domestic Supply ChainsCellibre received a $1.5 million award from the DoD's Distributed Bioindustrial Manufacturing Program to prepare for commercializing its biomanufacturing technologies for critical polymers, energetics, and platform chemicals. The funding aims to strengthen domestic supply chains and reduce reliance on foreign chemical production, which China now accounts for 44% of.